The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gastroparesis Treatment Market Research Report 2025
Synopsis
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
The global Gastroparesis Treatment market was valued at US$ 5659 million in 2023 and is anticipated to reach US$ 7087.8 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastroparesis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroparesis Treatment.
Report Scope
The Gastroparesis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastroparesis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroparesis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Abbott
Bausch Health
Boston Scientific
C.R. Bard
Johnson & Johnson
Cardinal Health
Evoke Pharma
Rhythm Pharmaceuticals
Segment by Type
Drug Treatment
Surgical Treatment
Segment by Application
Hospital
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastroparesis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
The global Gastroparesis Treatment market was valued at US$ 5659 million in 2023 and is anticipated to reach US$ 7087.8 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gastroparesis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroparesis Treatment.
Report Scope
The Gastroparesis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastroparesis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastroparesis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Abbott
Bausch Health
Boston Scientific
C.R. Bard
Johnson & Johnson
Cardinal Health
Evoke Pharma
Rhythm Pharmaceuticals
Segment by Type
Drug Treatment
Surgical Treatment
Segment by Application
Hospital
Ambulatory Surgical Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastroparesis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroparesis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Gastroparesis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastroparesis Treatment Market Perspective (2019-2030)
2.2 Gastroparesis Treatment Growth Trends by Region
2.2.1 Global Gastroparesis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gastroparesis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Gastroparesis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Gastroparesis Treatment Market Dynamics
2.3.1 Gastroparesis Treatment Industry Trends
2.3.2 Gastroparesis Treatment Market Drivers
2.3.3 Gastroparesis Treatment Market Challenges
2.3.4 Gastroparesis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastroparesis Treatment Players by Revenue
3.1.1 Global Top Gastroparesis Treatment Players by Revenue (2019-2024)
3.1.2 Global Gastroparesis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Gastroparesis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastroparesis Treatment Revenue
3.4 Global Gastroparesis Treatment Market Concentration Ratio
3.4.1 Global Gastroparesis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroparesis Treatment Revenue in 2023
3.5 Gastroparesis Treatment Key Players Head office and Area Served
3.6 Key Players Gastroparesis Treatment Product Solution and Service
3.7 Date of Enter into Gastroparesis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroparesis Treatment Breakdown Data by Type
4.1 Global Gastroparesis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Gastroparesis Treatment Forecasted Market Size by Type (2025-2030)
5 Gastroparesis Treatment Breakdown Data by Application
5.1 Global Gastroparesis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Gastroparesis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gastroparesis Treatment Market Size (2019-2030)
6.2 North America Gastroparesis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gastroparesis Treatment Market Size by Country (2019-2024)
6.4 North America Gastroparesis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastroparesis Treatment Market Size (2019-2030)
7.2 Europe Gastroparesis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gastroparesis Treatment Market Size by Country (2019-2024)
7.4 Europe Gastroparesis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastroparesis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Gastroparesis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gastroparesis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Gastroparesis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastroparesis Treatment Market Size (2019-2030)
9.2 Latin America Gastroparesis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gastroparesis Treatment Market Size by Country (2019-2024)
9.4 Latin America Gastroparesis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastroparesis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Gastroparesis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gastroparesis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Gastroparesis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Gastroparesis Treatment Introduction
11.1.4 Medtronic Revenue in Gastroparesis Treatment Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Gastroparesis Treatment Introduction
11.2.4 Abbott Revenue in Gastroparesis Treatment Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Bausch Health
11.3.1 Bausch Health Company Detail
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Gastroparesis Treatment Introduction
11.3.4 Bausch Health Revenue in Gastroparesis Treatment Business (2019-2024)
11.3.5 Bausch Health Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Detail
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Gastroparesis Treatment Introduction
11.4.4 Boston Scientific Revenue in Gastroparesis Treatment Business (2019-2024)
11.4.5 Boston Scientific Recent Development
11.5 C.R. Bard
11.5.1 C.R. Bard Company Detail
11.5.2 C.R. Bard Business Overview
11.5.3 C.R. Bard Gastroparesis Treatment Introduction
11.5.4 C.R. Bard Revenue in Gastroparesis Treatment Business (2019-2024)
11.5.5 C.R. Bard Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Gastroparesis Treatment Introduction
11.6.4 Johnson & Johnson Revenue in Gastroparesis Treatment Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Cardinal Health
11.7.1 Cardinal Health Company Detail
11.7.2 Cardinal Health Business Overview
11.7.3 Cardinal Health Gastroparesis Treatment Introduction
11.7.4 Cardinal Health Revenue in Gastroparesis Treatment Business (2019-2024)
11.7.5 Cardinal Health Recent Development
11.8 Evoke Pharma
11.8.1 Evoke Pharma Company Detail
11.8.2 Evoke Pharma Business Overview
11.8.3 Evoke Pharma Gastroparesis Treatment Introduction
11.8.4 Evoke Pharma Revenue in Gastroparesis Treatment Business (2019-2024)
11.8.5 Evoke Pharma Recent Development
11.9 Rhythm Pharmaceuticals
11.9.1 Rhythm Pharmaceuticals Company Detail
11.9.2 Rhythm Pharmaceuticals Business Overview
11.9.3 Rhythm Pharmaceuticals Gastroparesis Treatment Introduction
11.9.4 Rhythm Pharmaceuticals Revenue in Gastroparesis Treatment Business (2019-2024)
11.9.5 Rhythm Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Gastroparesis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Global Gastroparesis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Gastroparesis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gastroparesis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Gastroparesis Treatment Market Share by Region (2019-2024)
Table 8. Global Gastroparesis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Gastroparesis Treatment Market Share by Region (2025-2030)
Table 10. Gastroparesis Treatment Market Trends
Table 11. Gastroparesis Treatment Market Drivers
Table 12. Gastroparesis Treatment Market Challenges
Table 13. Gastroparesis Treatment Market Restraints
Table 14. Global Gastroparesis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Gastroparesis Treatment Market Share by Players (2019-2024)
Table 16. Global Top Gastroparesis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Treatment as of 2023)
Table 17. Ranking of Global Top Gastroparesis Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Gastroparesis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gastroparesis Treatment Product Solution and Service
Table 21. Date of Enter into Gastroparesis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastroparesis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Gastroparesis Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Gastroparesis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Gastroparesis Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Gastroparesis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Gastroparesis Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Gastroparesis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Gastroparesis Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Gastroparesis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Gastroparesis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Gastroparesis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Gastroparesis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Gastroparesis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Gastroparesis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Gastroparesis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Gastroparesis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Gastroparesis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gastroparesis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Gastroparesis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Gastroparesis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Gastroparesis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Gastroparesis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Gastroparesis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Gastroparesis Treatment Product
Table 49. Medtronic Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Abbott Company Detail
Table 52. Abbott Business Overview
Table 53. Abbott Gastroparesis Treatment Product
Table 54. Abbott Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. Bausch Health Company Detail
Table 57. Bausch Health Business Overview
Table 58. Bausch Health Gastroparesis Treatment Product
Table 59. Bausch Health Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 60. Bausch Health Recent Development
Table 61. Boston Scientific Company Detail
Table 62. Boston Scientific Business Overview
Table 63. Boston Scientific Gastroparesis Treatment Product
Table 64. Boston Scientific Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 65. Boston Scientific Recent Development
Table 66. C.R. Bard Company Detail
Table 67. C.R. Bard Business Overview
Table 68. C.R. Bard Gastroparesis Treatment Product
Table 69. C.R. Bard Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 70. C.R. Bard Recent Development
Table 71. Johnson & Johnson Company Detail
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Gastroparesis Treatment Product
Table 74. Johnson & Johnson Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Cardinal Health Company Detail
Table 77. Cardinal Health Business Overview
Table 78. Cardinal Health Gastroparesis Treatment Product
Table 79. Cardinal Health Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 80. Cardinal Health Recent Development
Table 81. Evoke Pharma Company Detail
Table 82. Evoke Pharma Business Overview
Table 83. Evoke Pharma Gastroparesis Treatment Product
Table 84. Evoke Pharma Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 85. Evoke Pharma Recent Development
Table 86. Rhythm Pharmaceuticals Company Detail
Table 87. Rhythm Pharmaceuticals Business Overview
Table 88. Rhythm Pharmaceuticals Gastroparesis Treatment Product
Table 89. Rhythm Pharmaceuticals Revenue in Gastroparesis Treatment Business (2019-2024) & (US$ Million)
Table 90. Rhythm Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroparesis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gastroparesis Treatment Market Share by Type: 2023 VS 2030
Figure 3. Drug Treatment Features
Figure 4. Surgical Treatment Features
Figure 5. Global Gastroparesis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Gastroparesis Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Ambulatory Surgical Center Case Studies
Figure 9. Others Case Studies
Figure 10. Gastroparesis Treatment Report Years Considered
Figure 11. Global Gastroparesis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Gastroparesis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Gastroparesis Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Gastroparesis Treatment Market Share by Players in 2023
Figure 15. Global Top Gastroparesis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroparesis Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Gastroparesis Treatment Revenue in 2023
Figure 17. North America Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Gastroparesis Treatment Market Share by Country (2019-2030)
Figure 19. United States Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Gastroparesis Treatment Market Share by Country (2019-2030)
Figure 23. Germany Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Gastroparesis Treatment Market Share by Region (2019-2030)
Figure 31. China Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Gastroparesis Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Gastroparesis Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Gastroparesis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Medtronic Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 46. Abbott Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 47. Bausch Health Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 48. Boston Scientific Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 49. C.R. Bard Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 51. Cardinal Health Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 52. Evoke Pharma Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 53. Rhythm Pharmaceuticals Revenue Growth Rate in Gastroparesis Treatment Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
